ALLMedicine™ Anovulation Center
Research & Reviews 616 results
https://clinicaltrials.gov/ct2/show/NCT05762822
Mar 10th, 2023 - Polycystic ovary syndrome (PCOS) affects 5-18% of women and is characterized by the presence of two of three of the Rotterdam criteria: Hyperandrogenism (clinical or biochemical), irregular menstrual cycles, and polycystic ovary morphology, after ...
https://doi.org/10.1080/14737159.2023.2177536
Expert Review of Molecular Diagnostics; Haddad-Filho H, Tosatti JAG et. al.
Mar 2nd, 2023 - Polycystic ovary syndrome (PCOS) is a condition that affects approximately 13% of reproductive age women and is characterized by androgen excess, menstrual irregularity and altered ovarian morphology. PCOS presents a complex etiology and pathophys...
https://clinicaltrials.gov/ct2/show/NCT03905603
Mar 2nd, 2023 - PCOS is a highly prevalent reproductive disorder characterized by hyperandrogenism (HA) and oligo/anovulation. PCOS is also associated with metabolic syndrome, obesity and insulin resistance. In young women with PCOS, several factors contribute to...
https://doi.org/10.1007/s13346-023-01304-z
Drug Delivery and Translational Research; Panchal D, Pandya T et. al.
Feb 24th, 2023 - Polycystic ovary syndrome (PCOS) is frequently diagnosed hormonal disorder with reproductive and metabolic complications. The most common symptoms include cyst in ovaries, anovulation, insulin resistance, and obesity. Clomiphene citrate, an ovulat...
https://clinicaltrials.gov/ct2/show/NCT05481684
Feb 24th, 2023 - The patients to be included in the study are the patients followed in the IVF centers of two different hospitals.Patients between the ages of 20-42 and having a BMI of <30, who are scheduled for IVF due to tubal factor, infertility of unknown caus...
Guidelines 1 results
https://doi.org/10.1210/jc.2017-00131
The Journal of Clinical Endocrinology and Metabolism; Gordon CM, Ackerman KE et. al.
Apr 4th, 2017 - The American Society for Reproductive Medicine, the European Society of Endocrinology, and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. To formulate clinical practice guidelines for the diagnosis and treatme...
Drugs 5 results see all →
Clinicaltrials.gov 147 results
https://clinicaltrials.gov/ct2/show/NCT05762822
Mar 10th, 2023 - Polycystic ovary syndrome (PCOS) affects 5-18% of women and is characterized by the presence of two of three of the Rotterdam criteria: Hyperandrogenism (clinical or biochemical), irregular menstrual cycles, and polycystic ovary morphology, after ...
https://clinicaltrials.gov/ct2/show/NCT03905603
Mar 2nd, 2023 - PCOS is a highly prevalent reproductive disorder characterized by hyperandrogenism (HA) and oligo/anovulation. PCOS is also associated with metabolic syndrome, obesity and insulin resistance. In young women with PCOS, several factors contribute to...
https://clinicaltrials.gov/ct2/show/NCT05481684
Feb 24th, 2023 - The patients to be included in the study are the patients followed in the IVF centers of two different hospitals.Patients between the ages of 20-42 and having a BMI of <30, who are scheduled for IVF due to tubal factor, infertility of unknown caus...
https://clinicaltrials.gov/ct2/show/NCT03306849
Feb 10th, 2023 - This study is being conducted in order to determine if ultrasound features of the ovaries can be used to reliably diagnose different types of anovulatory disorders in women across all body types. The study will also try to establish whether ultras...
https://clinicaltrials.gov/ct2/show/NCT05042895
Feb 8th, 2023 - Aim of the work The study aimed to evaluate post menstrual hysteroscopic findings in ovarian PCO and unexplained infertility and correlate them with TVS findings and final histopathologic diagnosis. Methodology: Study design: A cross-sectional stu...
News 95 results
https://www.medscape.com/viewarticle/980292
Sep 6th, 2022 - Polycystic ovary syndrome (PCOS) affects an estimated 8%-13% of women, and yet "it has been quite a black box for many years," as Margo Hudson, MD, an assistant professor of endocrinology, diabetes, and hypertension at Harvard Medical School, Bost...
https://www.mdedge.com/obgyn/article/257387/reproductive-endocrinology/state-science-pcos-emerging-neuroendocrine
Tara Haelle
Aug 26th, 2022 - Polycystic ovary syndrome (PCOS) affects an estimated 8%-13% of women, and yet “it has been quite a black box for many years,” as Margo Hudson, MD, an assistant professor of endocrinology, diabetes, and hypertension at Harvard Medical School, Bost.
https://www.medscape.com/viewarticle/976358
Jul 11th, 2022 - Wesley Burkett, MD Endometrial cancer (EC) is the most common gynecologic malignancy and is the fourth most common cancer seen in U.S. women. It is the only major cancer that has continued to see a rise in incidence and mortality for the past 2 de...
https://www.mdedge.com/obgyn/article/255740/gynecologic-cancer/racial-disparities-endometrial-cancer
Wesley Burkett, MD
Jun 23rd, 2022 - Endometrial cancer (EC) is the most common gynecologic malignancy and is the fourth most common cancer seen in U. S.
https://www.medscape.com/viewarticle/975815
Jun 17th, 2022 - Polycystic ovary syndrome (PCOS) in adolescents appears to present as two distinct subtypes based on the presence or absence of obesity, new data show. The findings support the "metabolic" and "reproductive" subtypes previously identified in adult...